The estimated Net Worth of Joan Danieley is at least $86.4 Tisíc dollars as of 17 December 2021. Joan Danieley owns over 21,481 units of agilon health, inc stock worth over $86,397 and over the last 4 years Joan sold AGL stock worth over $0.
Sign up
Joan Danieley AGL stock SEC Form 4 insiders trading
Joan has made over 2 trades of the agilon health, inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Joan exercised 21,481 units of AGL stock worth $95,590 on 17 December 2021.
The largest trade Joan's ever made was exercising 28,519 units of agilon health, inc stock on 15 December 2021 worth over $126,910. On average, Joan trades about 16,667 units every 1 days since 2021. As of 17 December 2021 Joan still owns at least 26,915 units of agilon health, inc stock.
You can see the complete history of Joan Danieley stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Joan Danieley's mailing address?
Joan's mailing address filed with the SEC is C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH, CA, 90831.
Insiders trading at agilon health, inc
Over the last 4 years, insiders at agilon health, inc have traded over $2,766,210,380 worth of agilon health, inc stock and bought 408,814 units worth $1,411,859 . The most active insiders traders include Investment Associates Ix, L..., Veeral Desai a Benjamin Shaker. On average, agilon health, inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,807,999. The most recent stock trade was executed by Benjamin Kornitzer on 14 March 2024, trading 5,434 units of AGL stock currently worth $17,443.
What does agilon health, inc's logo look like?
Complete history of Joan Danieley stock trades at agilon health, inc
agilon health, inc executives and stock owners
agilon health, inc executives and other stock owners filed with the SEC include:
-
Steven Jackson Sell,
Pres, CEO & Director -
Dr. Benjamin Kornitzer M.D.,
Chief Medical & Quality Officer -
Mat Varghese,
Chief People Officer -
Ben Shaker,
Chief Markets Officer -
Claire Mulhearn,
Chief Communications & Public Affairs Officer -
Lisa Ali,
Chief Compliance Officer -
Lyn Amor Macaraeg,
VP of Legal Services -
Matthew Dale Gillmor CFA,
VP of Investor Relations -
Girish Venkatachaliah,
Chief Technology Officer -
Timothy S. Bensley,
Chief Financial Officer -
Silvana Battaglia,
Director -
Timothy Bensley,
Chief Financial Officer -
Joan Danieley,
Chief Administrative Officer -
Theodore Halkias,
Chief Business Officer -
Michelle A Gourdine,
Director -
Veeral Desai,
Chief Strategy & Dev. Officer -
Lisa Dombro,
Exper. & Innovation Officer -
Clay Richards,
Director -
Sharad Mansukani,
Director -
Benjamin Kornitzer,
Chief Med. & Quality Officer -
Benjamin Shaker,
Chief Markets Officer -
Ronald A Williams,
Director -
Glenn Sobotka,
Chief Accounting Officer -
Girish Venkatachaliah,
Chief Technology Officer -
John William Wulf,
Director -
Michael L Smith,
Director -
Karen Mc Loughlin,
Director -
Richard J Schnall,
Director -
Investment Associates Ix, L...,
-
Steven Sell,
CEO & President -
Jeffrey A. Schwaneke,
Chief Financial Officer -
Diana Mckenzie,
Director -
Priscilla Kasenchak,
Chief Accounting Officer -
Timothy Gertsch,
Chief Accounting Officer